GGrantIndex
← Leaderboards

Dennis Ross-Degnan

Harvard Pilgrim Health Care, Inc.

$5,693,803
Attributed
$6,818,792
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $959K · FY201019
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

CDC$4,497,052 · 2
AHRQ$1,428,276 · 1
NIH$893,464 · 1

By mechanism

R01$2,321,740 · 2
U18$2,249,978 · 1
U58$2,247,074 · 1

Top collaborators

Most similar at Harvard Pilgrim Health Care, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Therapy Compliance

Research focus

Therapy ComplianceBehavioral /Social Science Research TagCaucasian AmericanCooperative StudyDiabetes MellitusDiabetes Mellitus TherapyDiabetic NephropathyDiabetic RetinopathyDisease /Disorder Proneness /RiskEpidemiologyExtended CareHuman DataAfrican AmericanHuman Therapy EvaluationLongitudinal Human StudyManaged CareMedical RecordsMetabolism Disorder ChemotherapyOutcomes ResearchPatient Oriented ResearchRacial /Ethnic DifferenceSelf CareHuman Subject

Grant awards (17)

Impact of HSA Cost Sharing Reductions on High-deductible Members with Diabetes$449,997
U18 · FY2019 · DP · contact PI
Impact of HSA Cost Sharing Reductions on High-deductible Members with Diabetes$449,997
U18 · FY2018 · DP · contact PI
Impact of HSA Cost Sharing Reductions on High-deductible Members with Diabetes$449,997
U18 · FY2017 · DP · contact PI
Impact of HSA Cost Sharing Reductions on High-deductible Members with Diabetes$449,997
U18 · FY2016 · DP · contact PI
Impact of HSA Cost Sharing Reductions on High-deductible Members with Diabetes$449,990
U18 · FY2015 · DP · contact PI
The Impact of Emerging Health Insurance Designs on Diabetes Outcomes and Disparit$493,962
U58 · FY2014 · DP · contact PI
Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population$465,027
R01 · FY2014 · HS · contact PI
Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population$480,571
R01 · FY2013 · HS · contact PI
The Impact of Emerging Health Insurance Designs on Diabetes Outcomes and Disparit$447,453
U58 · FY2013 · DP · contact PI
Evaluating Sequential Strategies to Reduce Readmission in a Diverse Population$482,678
R01 · FY2012 · HS · contact PI
The Impact of Emerging Health Insurance Designs on Diabetes Outcomes and Disparit$468,553
U58 · FY2012 · DP · contact PI
The Impact of Emerging Health Insurance Designs on Diabetes Outcomes and Disparit$418,553
U58 · FY2011 · DP · contact PI
The Impact of Emerging Health Insurance Designs on Diabetes Outcomes and Disparit$418,553
U58 · FY2010 · DP · contact PI
Race and Long-Term Diabetes Self-Management in an HMO$282,879
R01 · FY2004 · DK
Race and Long-Term Diabetes Self-Management in an HMO$283,345
R01 · FY2003 · DK
Race and Long-Term Diabetes Self-Management in an HMO$44,968
R01 · FY2003 · DK
Race and Long-Term Diabetes Self-Management in an HMO$282,272
R01 · FY2002 · DK